Cellbox Solutions has recruited Dr Gisèle Deblandre as Chief Scientific Officer. With her knowledge in the development of manufacturing processes and analytical methods for cell-based therapies and ex-vivo gene therapies, Deblandre will be responsible for the company's CGT division, developing the market for the company. In addition, her responsibilities will include the organisation and implementation of further scientific projects.
Deblandre brings decades of experience in molecular cell biology, developmental biology and related project management. For the past 20 years, she has also been responsible for team management in various disciplines of regenerative medicine. Most recently, Deblandre was Head of Science and Technology at Catalent Cell Therapy. Prior to that, she served as CSO at MaSTherCell. She holds a PhD in Molecular Cell Biology from the University of Brussels in Belgium.
"Gisèle Deblandre is a known name in the industry. Therefore, we are very proud to welcome her to the Cellbox Solutions team," says Prof Dr Kathrin Adlkofer, COO and founder of Cellbox Solutions. "As CSO in our company, Gisèle can combine her comprehensive knowledge and extensive experience to successfully establish the Cellbox in the field of cell & gene therapy.”
